Privacy Policy
  1. Home
  2. Privacy Policy
PYC Therapeutics (ASX: PYC): PYC is now funde...
By ACE Investors / 13 Aug 2025
Read More
Paradigm Biopharmaceuticals Limited (ASX: PAR...
By ACE Investors / 12 Aug 2025
Read More
Cigna Corp. (NYSE: CI): Targeting a long-term...
By ACE Investors / 11 Aug 2025
Read More
Compumedics Limited (ASX: CMP) – Delivers B...
By ACE Investors / 11 Aug 2025
Read More
RHYTHM Biosciences Limited (ASX: RHY) – Wel...
By ACE Investors / 08 Aug 2025
Read More
Mach7 Technologies Limited (ASX: M7T): Mach7 ...
By ACE Investors / 07 Aug 2025
Read More
DexCom Inc. (NASDAQ: DXCM): Significantly inc...
By ACE Investors / 06 Aug 2025
Read More
Imugene Limited (ASX: IMU): Azer-cel granted ...
By ACE Investors / 05 Aug 2025
Read More
Xenon Pharmaceuticals Inc (NASDAQ: XENE): Rob...
By ACE Investors / 01 Aug 2025
Read More
Clarity Pharmaceuticals Limited (ASX: CU6): P...
By ACE Investors / 31 Jul 2025
Read More
CervoMed Inc (NASDAQ: CRVO): A High-Value, Un...
By ACE Investors / 31 Jul 2025
Read More
Mesoblast Limited (ASX: MSB): The FDA provide...
By ACE Investors / 31 Jul 2025
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2025 ACE Investors. All Right Reserved. Design by Ace Investors